Related references
Note: Only part of the references are listed.Lowering of Glucose in Critical care: a randomized pilot trial
Joseph McMullin et al.
JOURNAL OF CRITICAL CARE (2007)
Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients
B Bakalar et al.
CRITICAL CARE MEDICINE (2006)
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels
TK Hansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients
C Goeters et al.
CRITICAL CARE MEDICINE (2002)
Infection, multiple organ failure, and survival in the intensive care unit: Influence of glutamine-supplemented parenteral nutrition on acquired infection
RD Griffiths et al.
NUTRITION (2002)
Intensive insulin therapy in critically ill patients.
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Impaired glucose metabolism predicts mortality after a myocardial infarction
J Bolk et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2001)
Plasma glutamine depletion and patient outcome in acute ICU admissions
HM Oudemans-van Straaten et al.
INTENSIVE CARE MEDICINE (2001)
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
SE Capes et al.
LANCET (2000)
Share Paper
